An INternational Frontline Ovarian cancer Real world Management study

Trial Identifier: D0817R00028
Sponsor: AstraZeneca
NCTID:: NCT04460768
Start Date: June 2020
Primary Completion Date: November 2020
Study Completion Date: November 2020
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Australia, Victoria Melbourne, Victoria, Australia, D0817R00028
South Korea Seoul, South Korea, D0817R00028
Taiwan, New Taipei City, Taiwan,, D0817R00028
Taiwan, Taipei City, Taiwan,, D0817R00028